- Home
- BNTC vs AMCX Comparison
BNTC vs AMCX Comparison
Compare BNTC & AMCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- AMCX
- Stock Information
- Founded
- BNTC 1995
- AMCX 1980
- Country
- BNTC United States
- AMCX United States
- Employees
- BNTC N/A
- AMCX N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- AMCX Cable & Other Pay Television Services
- Sector
- BNTC Health Care
- AMCX Telecommunications
- Exchange
- BNTC Nasdaq
- AMCX Nasdaq
- Market Cap
- BNTC 335.5M
- AMCX 292.9M
- IPO Year
- BNTC N/A
- AMCX 2011
- Fundamental
- Price
- BNTC $12.99
- AMCX $7.10
- Analyst Decision
- BNTC Strong Buy
- AMCX Sell
- Analyst Count
- BNTC 5
- AMCX 5
- Target Price
- BNTC $26.00
- AMCX $6.50
- AVG Volume (30 Days)
- BNTC 41.1K
- AMCX 830.5K
- Earning Date
- BNTC 09-25-2025
- AMCX 08-08-2025
- Dividend Yield
- BNTC N/A
- AMCX N/A
- EPS Growth
- BNTC N/A
- AMCX N/A
- EPS
- BNTC N/A
- AMCX N/A
- Revenue
- BNTC N/A
- AMCX $2,354,176,000.00
- Revenue This Year
- BNTC N/A
- AMCX N/A
- Revenue Next Year
- BNTC N/A
- AMCX N/A
- P/E Ratio
- BNTC N/A
- AMCX N/A
- Revenue Growth
- BNTC N/A
- AMCX N/A
- 52 Week Low
- BNTC $8.06
- AMCX $5.41
- 52 Week High
- BNTC $17.15
- AMCX $10.72
- Technical
- Relative Strength Index (RSI)
- BNTC 58.50
- AMCX 62.15
- Support Level
- BNTC $12.04
- AMCX $6.68
- Resistance Level
- BNTC $13.09
- AMCX $7.33
- Average True Range (ATR)
- BNTC 0.63
- AMCX 0.42
- MACD
- BNTC 0.18
- AMCX 0.05
- Stochastic Oscillator
- BNTC 93.47
- AMCX 56.80
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About AMCX AMC Networks Inc.
AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.